Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Ruzasvir

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Larimar Therapeutics Reports Q3 2024 Finacial Results
    Larimar Therapeutics Reports Q3 2024 Finacial Results

    30 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/30/2971559/0/en/Larimar-Therapeutics-Reports-Third-Quarter-2024-Operating-and-Financial-Results.html

    GLOBENEWSWIRE
    30 Oct 2024
    Share Share
    Atea Pharma Presents Promising Bemnifosbuvir and Ruzasvir Combination Data
    Atea Pharma Presents Promising Bemnifosbuvir and Ruzasvir Combination Data

    13 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/13/2778876/0/en/Atea-Pharmaceuticals-Presents-Promising-Bemnifosbuvir-and-Ruzasvir-Combination-Data-for-the-Treatment-of-Hepatitis-C-Virus-at-AASLD-The-Liver-Meeting-2023.html

    GLOBENEWSWIRE
    13 Nov 2023
    Share Share
    Atea to Present Bemnifosbuvir and Ruzasvir Data for Hepatitis C Virus
    Atea to Present Bemnifosbuvir and Ruzasvir Data for Hepatitis C Virus

    02 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/02/2772115/0/en/Atea-Pharmaceuticals-to-Present-Bemnifosbuvir-and-Ruzasvir-Data-for-the-Treatment-of-Hepatitis-C-Virus-at-AASLD-The-Liver-Meeting-2023.html

    GLOBENEWSWIRE
    02 Nov 2023
    Share Share